Literature DB >> 20059993

Hs2st mediated kidney mesenchyme induction regulates early ureteric bud branching.

Mita M Shah1, Hiroyuki Sakurai, Derina E Sweeney, Thomas F Gallegos, Kevin T Bush, Jeffrey D Esko, Sanjay K Nigam.   

Abstract

Heparan sulfate proteoglycans (HSPGs) are central modulators of developmental processes likely through their interaction with growth factors, such as GDNF, members of the FGF and TGFbeta superfamilies, EGF receptor ligands and HGF. Absence of the biosynthetic enzyme, heparan sulfate 2-O-sulfotransferase (Hs2st) leads to kidney agenesis. Using a novel combination of in vivo and in vitro approaches, we have reanalyzed the defect in morphogenesis of the Hs2st(-)(/)(-) kidney. Utilizing assays that separately model distinct stages of kidney branching morphogenesis, we found that the Hs2st(-/-) UB is able to undergo branching and induce mesenchymal-to-epithelial transformation when recombined with control MM, and the isolated Hs2st null UB is able to undergo branching morphogenesis in the presence of exogenous soluble pro-branching growth factors when embedded in an extracellular matrix, indicating that the UB is intrinsically competent. This is in contrast to the prevailing view that the defect underlying the renal agenesis phenotype is due to a primary role for 2-O sulfated HS in UB branching. Unexpectedly, the mutant MM was also fully capable of being induced in recombination experiments with wild-type tissue. Thus, both the mutant UB and mutant MM tissue appear competent in and of themselves, but the combination of mutant tissues fails in vivo and, as we show, in organ culture. We hypothesized a 2OS-dependent defect in the mutual inductive process, which could be on either the UB or MM side, since both progenitor tissues express Hs2st. In light of these observations, we specifically examined the role of the HS 2-O sulfation modification on the morphogenetic capacity of the UB and MM individually. We demonstrate that early UB branching morphogenesis is not primarily modulated by factors that depend on the HS 2-O sulfate modification; however, factors that contribute to MM induction are markedly sensitive to the 2-O sulfation modification. These data suggest that key defect in Hs2st null kidneys is the inability of MM to undergo induction either through a failure of mutual induction or a primary failure of MM morphogenesis. This results in normal UB formation but affects either T-shaped UB formation or iterative branching of the T-shaped UB (possibly two separate stages in collecting system development dependent upon HS). We discuss the possibility that a disruption in the interaction between HS and Wnts (e.g. Wnt 9b) may be an important aspect of the observed phenotype. This appears to be the first example of a defect in the MM preventing advancement of early UB branching past the first bifurcation stage, one of the limiting steps in early kidney development. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20059993      PMCID: PMC2834281          DOI: 10.1016/j.ydbio.2009.12.033

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  58 in total

1.  Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system.

Authors:  Thomas J Carroll; Joo-Seop Park; Shigemi Hayashi; Arindam Majumdar; Andrew P McMahon
Journal:  Dev Cell       Date:  2005-08       Impact factor: 12.270

2.  Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct.

Authors:  Akito Maeshima; Duke A Vaughn; Yohan Choi; Sanjay K Nigam
Journal:  Dev Biol       Date:  2006-04-27       Impact factor: 3.582

3.  Shedding light on the distinct functions of proteoglycans.

Authors:  Scott B Selleck
Journal:  Sci STKE       Date:  2006-04-04

Review 4.  Dissecting stages of mesenchymal-to-epithelial conversion during kidney development.

Authors:  Kai M Schmidt-Ott; Debin Lan; Benjamin J Hirsh; Jonathan Barasch
Journal:  Nephron Physiol       Date:  2006-05-24

5.  Heregulin induces glial cell line-derived neurotrophic growth factor-independent, non-branching growth and differentiation of ureteric bud epithelia.

Authors:  Hiroyuki Sakurai; Kevin T Bush; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2005-09-23       Impact factor: 5.157

6.  Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis.

Authors:  Lars Jakobsson; Johan Kreuger; Katarina Holmborn; Lars Lundin; Inger Eriksson; Lena Kjellén; Lena Claesson-Welsh
Journal:  Dev Cell       Date:  2006-05       Impact factor: 12.270

7.  Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function.

Authors:  Kay Grobe; Masaru Inatani; Srinivas R Pallerla; Jan Castagnola; Yu Yamaguchi; Jeffrey D Esko
Journal:  Development       Date:  2005-07-14       Impact factor: 6.868

8.  Mice deficient in Ext2 lack heparan sulfate and develop exostoses.

Authors:  Dominique Stickens; Beverly M Zak; Nathalie Rougier; Jeffrey D Esko; Zena Werb
Journal:  Development       Date:  2005-10-19       Impact factor: 6.868

9.  Analysis of metagene portraits reveals distinct transitions during kidney organogenesis.

Authors:  Igor F Tsigelny; Valentina L Kouznetsova; Derina E Sweeney; Wei Wu; Kevin T Bush; Sanjay K Nigam
Journal:  Sci Signal       Date:  2008-12-09       Impact factor: 8.192

10.  Atlas of gene expression in the developing kidney at microanatomic resolution.

Authors:  Eric W Brunskill; Bruce J Aronow; Kylie Georgas; Bree Rumballe; M Todd Valerius; Jeremy Aronow; Vivek Kaimal; Anil G Jegga; Jing Yu; Sean Grimmond; Andrew P McMahon; Larry T Patterson; Melissa H Little; S Steven Potter
Journal:  Dev Cell       Date:  2008-11       Impact factor: 12.270

View more
  19 in total

Review 1.  Extracellular matrix and cytoskeletal dynamics during branching morphogenesis.

Authors:  Hye Young Kim; Celeste M Nelson
Journal:  Organogenesis       Date:  2012-04-01       Impact factor: 2.500

Review 2.  Specific sides to multifaceted glycosaminoglycans are observed in embryonic development.

Authors:  Kenneth L Kramer
Journal:  Semin Cell Dev Biol       Date:  2010-07-03       Impact factor: 7.727

Review 3.  Concise review: can the intrinsic power of branching morphogenesis be used for engineering epithelial tissues and organs?

Authors:  Sanjay K Nigam
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

Review 4.  The function of heparan sulfate during branching morphogenesis.

Authors:  Vaishali N Patel; Dallas L Pineda; Matthew P Hoffman
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

Review 5.  Deciphering functional glycosaminoglycan motifs in development.

Authors:  Robert A Townley; Hannes E Bülow
Journal:  Curr Opin Struct Biol       Date:  2018-03-24       Impact factor: 6.809

6.  Growth factor-dependent branching of the ureteric bud is modulated by selective 6-O sulfation of heparan sulfate.

Authors:  Mita M Shah; Hiroyuki Sakurai; Thomas F Gallegos; Derina E Sweeney; Kevin T Bush; Jeffrey D Esko; Sanjay K Nigam
Journal:  Dev Biol       Date:  2011-05-11       Impact factor: 3.582

Review 7.  Growth factor-heparan sulfate "switches" regulating stages of branching morphogenesis.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Pediatr Nephrol       Date:  2014-02-02       Impact factor: 3.714

8.  Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling.

Authors:  Omai B Garner; Kevin T Bush; Kabir B Nigam; Yu Yamaguchi; Ding Xu; Jeffrey D Esko; Sanjay K Nigam
Journal:  Dev Biol       Date:  2011-05-07       Impact factor: 3.582

9.  N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland.

Authors:  Kevin T Bush; Brett E Crawford; Omai B Garner; Kabir B Nigam; Jeffrey D Esko; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

10.  Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice.

Authors:  Brett E Crawford; Omai B Garner; Joseph R Bishop; David Y Zhang; Kevin T Bush; Sanjay K Nigam; Jeffrey D Esko
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.